secwatch.observer — SEC 8-K summary
======================================

Issuer:     CareDx, Inc. (CDNA)
CIK:        0001217234
Form:       8-K
Filed at:   2024-10-15T23:59:59+00:00
Accession:  0001193125-24-237218
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

CareDx reports preliminary Q3 revenue of $82-83M, up 23% YoY; testing volume rises 16%
--------------------------------------------------------------------------------

- Preliminary Q3 2024 revenue $82-83M, up ~23% YoY; testing services $60-61M (+26%).
- Testing volume ~44,600 tests, up ~16% YoY; includes $1.2M from prior quarters.
- Patient & Digital Solutions rev ~$11.9M (+20%); Products rev ~$10.2M (+7%).
- Cash and marketable securities ~$240M, no debt; strong balance sheet.
- Full Q3 results to be reported on November 4, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1217234/000119312524237218/0001193125-24-237218-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1217234/000119312524237218/d889373d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-237218

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer